INTRODUCTION
Long-range enhancers physically contact their target promoters to form chromatin loops. The b-globin locus has been at the forefront of studies on the dynamics and mechanisms of chromatin looping and gene regulation. In erythroid cells, a powerful distal enhancer called the locus control region (LCR), composed of multiple DNase I hypersensitive sites (HSs), is in physical proximity to the b-globin genes in a developmentally dynamic manner (Carter et al., 2002; Tolhuis et al., 2002) . In primitive murine erythroid cells, the LCR loops to the embryonic-type b-globin gene promoters (εy and bh1), whereas in definitive erythroid cells, the LCR exclusively contacts the adult-type b-globin genes (b-major and b-minor), with the intervening embryonic globin genes looped out (Palstra et al., 2003) . Humans additionally bear fetal stage-specific b-like globin (g-globin) genes that contact the LCR and are transcribed from the beginning of fetal liver erythropoiesis until birth when blood formation gradually shifts to the bone marrow. Several transcription factors have been implicated in loop formation at the b-globin locus, including Klf1, GATA1, and its coregulators Ldb1 and FOG1 (Drissen et al., 2004; Song et al., 2007; Vakoc et al., 2005) . In previous work we addressed whether any of these factors might be sufficient for chromatin looping and whether looping is a causal event during transcription initiation or merely a reflection of it (Deng et al., 2012) . Specifically, in immature murine erythroblasts in which the b-globin promoter is not in contact with the LCR, tethering of Ldb1 to the promoter via artificial zinc-finger (ZF) proteins established an LCR-promoter loop similar to that observed in mature erythroid cells and stimulated transcription (Deng et al., 2012) . The self-association (SA) domain of Ldb1 was sufficient for this activity. These results demonstrated that forced juxtaposition of an enhancer and promoter via chromatin looping can trigger gene activation and identified a relatively small functional domain of Ldb1 as a powerful mediator of such long-range interactions. Therefore, it should be possible to activate any other similarly regulated nearby gene by producing an interaction between it and the active LCR.
The molecular mechanisms mediating the developmental switch in globin gene expression have been widely investigated. A variety of nuclear complexes contribute to the silencing of the embryonic and fetal globin genes in adult erythroid cells . Among these, arguably the most powerful one is nucleated by Bcl11a (Sankaran et al., 2008 (Sankaran et al., , 2009 ), which does not bind directly to promoters of the silenced human fetal globin genes but seems to repress them via a mechanism involving higher-order chromatin looping (Kiefer et al., 2011; Xu et al., 2010) . Hence, manipulating chromatin loops might be a viable strategy to reverse the globin switch. The overarching interest in these questions stems in part from the clinical importance of understanding hemoglobin switching. Patients affected by sickle cell anemia and b-thalassemia experience a milder course of the disease if they express elevated levels of fetal hemoglobin in adulthood (Platt et al., 1994; Weatherall, 2001 ). This observation in particular provided a major impetus for studies over the last decades aimed at unraveling the mechanisms by which the fetal globin genes are silenced with the ultimate goal of reactivating their expression.
Here, we tested whether developmentally silenced embryonic or fetal globin genes can be reactivated in adult erythroid cells by juxtaposing them with the LCR and whether reactivation would lead to a concomitant reduction in the adult-type globin genes. We found that ZF mediated tethering of the SA domain of Ldb1 to the murine embryonic bh1-globin promoter activated transcription in an adult-type erythroblast cell line and primary definitive erythroid cells. This activity was abrogated in erythroid cells from mice in which the LCR had been deleted, demonstrating that embryonic globin gene activation was dependent on a long-range LCR interaction. Primary human erythroid cells expressing the SA domain fused to a ZF moiety that targets the g-globin promoters produced high quantities of g-globin mRNA and protein in the vast majority of cells with an accompanying reduction in adult-type globin expression. The reciprocal alteration in fetal versus adult globin gene transcription was reflected in corresponding changes in contact frequencies with the LCR.
Together, these studies demonstrate that stringent developmental regulation of a gene can be overcome through the manipulation of higher-order chromatin structure and that such manipulations have the potential for therapeutic applications.
RESULTS

bh1-SA-Mediated Activation of an Embryonic Globin Gene in Adult Erythroblasts
To examine the potential of forced gene looping in reprogramming the b-globin locus, we began by using G1E erythroblasts. G1E is a murine adult-type erythroid cell line that lacks the erythroid transcription factor GATA1 (Weiss et al., 1997) . As a result, a productive interaction between the LCR and the adult b-globin (b-major) promoter fails to form, and b-major mRNA production is low (Vakoc et al., 2005) . GATA1 deficiency is associated with little to no Ldb1 recruitment to the promoter (Tripic et al., 2009) . Tethering Ldb1 or its SA domain to the b-major promoter restored looping in a manner highly similar to that in normal erythroid cells or G1E cells upon GATA1 restoration (Deng et al., 2012) . Here, we asked whether a similar approach could be employed to achieve a distinct goal, which is to activate the embryonic bh1-globin gene by tethering the Ldb1 SA domain to its promoter to induce an interaction with the LCR ( Figure 1A ). We designed custom ZF proteins and screened them for binding to bh1-globin promoter sequences in vitro (see the Experimental Procedures). Functional proteins were fused to the SA domain of Ldb1 (bh1-SA) and introduced into G1E cells by retroviral infection. Infected cells were isolated by fluorescence-activated cell sorting (FACS). Chromatin immunoprecipitation (ChIP) revealed specific binding of bh1-SA to the bh1-globin promoter, but not to the promoters of the other b-like globin genes ( Figure 1B ). We observed a low but reproducible ChIP signal at the DNase 1 hypersensitive (HS) sites of the LCR, likely due to bh1-SA binding to endogenous Ldb1-containing complexes (Deng et al., 2012) . We next examined the effects of bh1-SA on bh1-globin transcription by qRT-PCR. bh1-globin mRNA levels were increased 368-fold over nonexpressing G1E cells or cells that express a ZF protein targeting HS2 of the LCR (L-SA) ( Figure 1C ).
Restoration of GATA1 activity in G1E cells via expression of an estradiol-inducible form of GATA1 (GATA1-ER) leads to erythroid maturation and high-level induction of b-major transcription, as well as low-level induction of bh1-globin ( Figures 1C and 1D ) (Weiss et al., 1997; Welch et al., 2004) . Hence, we investigated whether bh1-SA expression was capable of raising bh1-globin transcription in differentiating b-major producing erythroid cells. Notably, bh1-SA induced bh1-globin levels 26-fold over control cells, amounting to 15% of total b-globin expression compared to 0.5% in vector only containing cells ( Figures 1C and 1D ). Tethering the SA domain to the LCR (L-SA in Figure 1 ) or b-major promoter (Deng et al., 2012 ; data not shown) did not activate bh1-globin expression, confirming that the effects of bh1-SA are specific. Basal-level bh1-globin expression and bh1-SA-induced bh1-globin transcription were higher in GATA1 replete cells when compared to parental G1E cells, likely due to increased LCR and promoter activities in the presence of GATA1 (Figure S1A available online) . The substantial increase in bh1-globin expression was associated with a trend toward lower b-major expression (see also below) but without significant changes of other erythroid genes, including those encoding a-globin and Kit, indicating that the effects of bh1-SA are not simply a consequence of differentiation induction ( Figures 1D and S1B ).
bh1-SA-Mediated Activation of Embryonic Globin Gene Expression in Primary Adult Erythroblasts
To address whether bh1-SA activates expression of bh1-globin in murine primary erythroid cells, we isolated immature definitive (adult-type) erythroid progenitor cells from E13.5 wild-type fetal livers by sorting for CD71 medium/low and Ter119 low populations (S0 cells) as described previously (Figure 2A ) (Pop et al., 2010) . Cells were infected with a retroviral vector expressing bh1-SA (infection rate >75%; data not shown) and expanded for 48 hr, followed by measurements of transcript levels by RTqPCR (reverse transcription quantitative polymerase chain reaction). bh1-SA activated bh1-globin transcription by almost 800-fold compared to empty vector control ( Figure 2B ), exceeding 30% of total b-globin synthesis ( Figure 2C ). We noted that the zinc finger alone also raised bh1-globin expression but only to 1/6 of the levels achieved by bh1-SA ( Figures 2B and 2C) . Although the cause for this activity is unclear, we surmise that zinc-finger binding might increase chromatin occupancy of nearby activators (Adams and Workman, 1995) , which in turn contribute to LCR recruitment.
We also examined the ability of bh1-SA to increase bh1-globin expression in erythroblasts that are further differentiated (S1 populations) and obtained similar results (Figures S2A and S2B) . Importantly, b-major expression was slightly reduced in both bh1-SA-expressing populations ( Figures 2B and S2A) , consistent with the idea that bh1-SA recruits the LCR toward the bh1-globin gene at the expense of the b-major gene. We noted that bh1-SA impaired expression of a few erythroid specific genes, such as those encoding Band3, AHSP, and Alas2 ( Figure S2C ). Because these genes are in part regulated by promoter proximal Ldb1-containing transcription factor complexes (Tripic et al., 2009 ), bh1-SA likely influences their expression in a dominant-negative fashion, especially when expressed very highly (data not shown). However, in human erythroblasts, SAfusion proteins did not inhibit the orthologous genes (see below), which might be due to species-specific effects and/or lower expression levels. Nevertheless, these events do not substantially impact overall erythroid maturation and a-globin gene expression, indicating that bh1-globin activation is gene specific and not the result of global differentiation induction.
Interestingly, the embryonic globin gene εy, which is located closer to the LCR than the bh1 gene, was also activated to some degree by bh1-SA expression in both S0 and S1 erythroid precursor cells ( Figure S2D ). Since bh1-SA does not detectably bind to the εy-globin gene promoter ( Figure 1B ), this suggests that bringing the LCR closer into the vicinity of the εy-globin gene increases its likelihood of expression.
In sum, recruitment of the Ldb1 SA domain to the bh1-globin promoter is capable of substantially antagonizing the stringent developmental silencing mechanisms operational in definitive murine erythroid cells. If a similar degree of reactivation of fetal globin genes could be achieved in adult human erythroid cells, this would be highly therapeutically relevant (Platt, 2008) .
bh1-SA Activation of bh1-Globin Expression Is LCR Dependent Based on our prior studies showing that tethering of Ldb1 to the b-globin promoter triggers looping (Deng et al., 2012) , the mechanism by which bh1-SA activates gene expression most likely also involves promoting proximity between the bh1-globin gene and the LCR. To test this directly, we carried out chromosome conformation capture (3C) experiments in G1E cells expressing bh1-SA. However, the relatively short genomic distance between the LCR and the bh1-globin gene as well as the intervening εy-globin gene produced high basal-level 3C signals. Moreover, because the activation of bh1-globin expression ranged around 15% of total b-globin synthesis, the signal-to-noise ratio of the 3C experiments was not high enough to allow reliable detection of changes in contact frequencies (data not shown). As an alternative approach, we carried out genetic experiments using erythroid cells from mice lacking the LCR (DLCR) that contain a transgenic human b-globin locus to support erythropoiesis (Bender et al., 2000) ( Figure 3A ). If long-range LCR looping underlies bh1-SA function, the LCR deletion should impair bh1-SA activity. If, on the other hand, bh1-SA bypasses the requirement for the LCR by functioning locally as a strong transcriptional activator, its activity should be independent of the LCR ( Figures 1A and 3A) .
bh1-SA was introduced into primary erythroid precursor cells (S0 populations, gated as in Figure 2A ) isolated from E13.5 fetal livers derived from mice homozygous for the LCR deletion. Although the loss of the LCR had no impact on basal level bh1-globin transcription, it completely abrogated the induction of bh1-globin expression seen in the wild-type mice ( Figure 3B ). As expected, b-major expression in the DLCR cells was low when compared with wild-type cells ( Figure 3C) . Transcription of the a-globin gene that resides on a different chromosome was unaffected by the LCR deletion ( Figure 3D ). Adventitious activation of εy-globin expression was also abrogated in the absence of the LCR ( Figure S3A ), consistent with a model in which the LCR can form productive sporadic contacts with nearby genes (Noordermeer et al., 2011) . Similar results were obtained using purified S1 cell populations ( Figure S3B ). In conclusion, bh1-SA-mediated activation of bh1-globin transcription requires the LCR and, by extension, is dependent on chromatin looping. 3C experiments carried out in human erythroid cells further support the concept that zinc-finger SA fusion proteins alter chromosome looping (see below).
Zinc Finger-SA-Mediated Activation of g-Globin Transcription in Primary Adult Human Erythroid Cells We next explored whether the strategy of forced chromatin looping could be employed to activate g-globin expression in adult human erythroid cells ( Figure 4A ). To tether the Ldb1 SA domain to the two highly similar G g-globin and A g-globin genes, we fused it to a previously characterized artificial zinc-finger protein (called GG1) that targets both promoters (Grä slund et al., 2005) . The fusion construct (GG1-SA) was HA-tagged and inserted upstream of an IRES-GFP cassette into a lentiviral vector containing the promoter of either the ANK1 (ankyrin 1) or SPTB (spectrin) genes to drive erythroid-specific expression (Wilber et al., 2010) . As a control, we used a construct containing just the g-globin binding zinc-finger protein (GG1-Only). To assess DNA binding specificity of GG1-SA in vivo, constructs were introduced into the human hematopoietic cell line K562 and analyzed by anti-HA ChIP. GG1-SA targeting was highly specific for the g-globin promoters with little or no signal at the other globin promoters ( Figure 4B ). To determine whether GG1-SA augments g-globin expression in primary adult human erythroid cells, we collected bone marrow-derived human CD34+ hematopoietic progenitor cells and differentiated them toward the erythroid lineage using a previously described two-phase liquid culture system involving an expansion and differentiation phase (Sankaran et al., 2008) ( Figure 4C ). Cells were infected with lentivirus containing GG1 constructs during the expansion phase and sorted for GFP expression on day 10-12 of erythroid differentiation. GFPnegative cells served as controls. Sorting yielded pure populations of cells (Figure S4A) expressing comparable amounts of GG1-SA or GG1-Only mRNA (Figure S4B) . Remarkably, GG1-SA-expressing cells produced g-globin approximating 85% of total globin synthesis (defined as g-globin plus b-globin) compared with 25% in GFP-negative cells ( Figure 4D ).
Basal levels of g-globin expression can rise upon exposure of human erythroblasts to in vitro culture conditions (Fibach et al., 1993; Sankaran et al., 2008) . This is consistent with the human fetal genes being silenced less stringently compared to the murine embryonic globin genes (Sankaran et al., 2009 ). Nevertheless, GG1-SA induced g-globin levels that rival or exceed those achieved by pharmacological g-globin inducers (Atweh and Fathallah, 2010; Bradner et al., 2010; Cao et al., 2004; Smith et al., 2000) or depletion of Bcl11a (Sankaran et al., 2008; Xu et al., 2013) .
We observed considerable variation in basal g-globin expression among donors ranging from <10% to 50% of total globin synthesis ( Figure S4C ). As erythroid cells undergo maturation, the ratio of fetal to adult hemoglobin declines. To ensure that our observed increases in fetal globin production are not confounded by variable rates of erythroid maturation due to cell culture and donor variations and/or secondary to GG1-SA expression, we normalized g-globin transcripts against a-globin mRNA as an indicator of erythroid differentiation (Pope et al., 2000) . GG1-SA induced a 2.5-fold increase in g-globin expression compared to GG1-Only and control (sorted GFP-negative cells) populations ( Figures 4E and S4D) . Importantly, GG1-SA expression resulted in a marked reduction in b-globin transcription (13.5% versus control and 18.1% versus GG1-Only) ( Figures  4E and S4D) . Because the sum of g-globin and b-globin transcripts remained similar vis-à -vis a-globin mRNA levels, this further supports the idea that GG1-SA functions via competition for the LCR. Similar reciprocal changes in globin transcription upon GG1-SA expression were observed when mRNA levels were normalized to GAPDH ( Figure S4E ). Finally, GG1-SA expression measurably increased the expression of the surface marker CD235a (Figure S4F ), suggesting that GG1-SA might enhance erythroid maturation. This prompted us to assess a panel of erythroid genes, which revealed a modest (%2-fold) increase of a subset of these ( Figure S4G ), suggesting that the increased g-to b-globin ratio is not due to GG1-SA-mediated alterations in erythroid differentiation. Together, these results demonstrate that GG1-SA strongly induces the expression of g-globin, with resulting loss in b-globin transcription.
GG1-SA-Mediated Induction of Fetal Hemoglobin in Peripheral Blood-Derived Erythroid Precursor Cells
We next examined whether the GG1-SA-induced increase in g-globin mRNA transcription is reflected in fetal hemoglobin production at the protein level. CD34+ progenitor cells isolated from peripheral blood were expanded, lentivirally infected, and differentiated toward the erythroid lineage as described previously (Breda et al., 2012) . Hemoglobin profiles were determined by high-performance liquid chromatography (HPLC). GG1-SA expression led to a dramatic increase in the percentage of HbF compared to uninfected controls or GG1-Only (Figures 5A and  S5A ; data not shown). Correspondingly, adult hemoglobin levels (HbA and HbA2) declined markedly. These results match those measuring g-globin and b-globin mRNA levels from these populations (data not shown). Similarly, we observed a dramatic rise in absolute HbF production (as measured in micrograms of protein) with a concomitant reduction in HbA levels ( Figure 5B ). This shift in hemoglobin production is likely an underestimate because GG1-expressing cells were not enriched by cell sorting in these experiments. Importantly, total hemoglobin production remained unchanged between controls and GG1-SA containing cells (Figure 5B ), indicating that in these experiments GG1-SA expression did not significantly affect overall erythroid maturation.
Finally, we followed the effects of GG1-SA at two stages of differentiation (day 4 and day 8) of peripheral blood-derived erythroid cells by analyzing globin mRNA levels and cell surface marker expression. At day 4 of erythroid differentiation, GG1-SA strongly stimulated g-globin transcription compared to controls with high levels being sustained at day 8 ( Figure S5B ). GG1-SA also attenuated b-globin transcription at both time points ( Figure S5B ). GG1-SA did not impair erythroid differentiation but slightly promoted it as measured by CD235a surface expression ( Figure S5C ), similar to the results obtained with bone marrow-derived cells. Taken together, these results demonstrate potent induction of HbF by GG1-SA at distinct stages of erythroid differentiation and independent of stem cell source.
Cellular Distribution of g-Globin Protein in Adult
Erythroid Cells Containing GG1-SA Fetal hemoglobin (HbF) production is heterocellular in normal individuals in whom a small proportion of cells with high level of HbF accounts for the overall low HbF levels (Boyer et al., 1975; Wood et al., 1975) . We examined the cellular distribution of HbF in GG1-SA and GG1-Only-expressing bone marrowderived cultures by staining with an anti-HbF antibody, followed by flow cytometry and immunofluorescence microscopy. GG1-SA resulted in nearly pancellular HbF expression, whereas GG1-Only triggered expression merely in a subset of cells (Figure 6) , consistent with the mRNA analyses. This observation further highlights the effectiveness of GG1-SA in stimulating fetal globin synthesis.
GG1-SA Induces g-Globin Promoter-LCR Looping
Several lines of evidence support the model that zinc finger-SA fusion proteins work via a looping mechanism, including their reciprocal effects on embryonic/fetal and adult globin expression, the dependence on the LCR for activity, and prior 3C studies, demonstrating the ability of Ldb1 and its SA domain to trigger chromatin looping (Deng et al., 2012; Song et al., 2007) . To directly assess the effects of GG1-SA expression on chromatin contacts within the b-globin locus, we carried out 3C experiments in adult erythroblasts. GG1-SA expression established a strong interaction between the LCR and the g-globin genes that is absent in control cells (Figure 7) . Please note that the primer pair (Gg) used for the two g-globin promoters does not distinguish between these sequences, and the values represent the average normalized signals from both (Kiefer et al., 2011) . The contact frequencies of the intervening restriction fragment (primer pair G/A) between the two g-globin genes are also increased, albeit not as much as the g-genes themselves. Additionally, interactions between the LCR and the adult globin genes (d-and b-globin) were diminished, consistent with GG1-SA competitively reconfiguring looped contacts toward g-globin promoter at the expense of the b-globin promoter. In light of the variation among donor samples leading to sizeable error bars, we plotted the individual 3C experiments showing essentially the same results in all samples ( Figure S6A ). Finally, results were robust toward different ways of normalizing the data (Figure S6B ; data not shown). In sum, tethering the SA portion of Ldb1 to the fetal globin promoters promotes their juxtaposition, with the LCR leading to transcription activation, with accompanying reduction in the expression of adult globin genes.
DISCUSSION
Here, we reprogrammed a developmentally regulated gene locus by manipulating its chromatin organization. In adult erythroid cells, redirecting the LCR to the silenced embryonic or fetal b-type globin promoters by targeted tethering of the Ldb1 SA domain strongly activated transcription at the expense of the adult b-globin genes, thus at least partially reversing the developmental gene switch ( Figure 7B ). Our findings support that chromatin looping plays an essential role in controlling globin switching and suggest a possible strategy for the treatment of those hemoglobinopathies that would benefit from the activation of alternative b-like globin genes. More broadly, they exemplify controlled manipulation of chromatin folding in the nucleus as a novel and powerful strategy to modulate, positively or negatively, the transcription of designated genes.
Central to the mechanism of globin gene switching is the exclusive interaction between the LCR and globin gene promoters at distinct developmental stages (Carter et al., 2002; Palstra et al., 2008; Tolhuis et al., 2002) . In adult-type murine erythroid cells, Ldb1 is required for the juxtaposition between the LCR and the adult b-major globin gene (Deng et al., 2012; Song et al., 2007) . The present results indicate that the Ldb1 SA domain is also capable of forging a chromatin interaction between the LCR and globin genes that represents earlier stages of development, leading to marked increases in transcription.
Several lines of evidence strongly support loop formation as the underlying mechanism of transcriptional activation. First, deletion of the LCR essentially abrogated the effects of the tethered Ldb1 SA domain, indicating that it does not substitute for the LCR by simply enhancing promoter activity but instead requires long-range LCR action. Second, increases in embryonic or fetal globin gene expression were accompanied by a reciprocal decrease in adult b-globin expression, consistent with competition for long-range LCR activity. Third, 3C experiments revealed that GG1-SA expression strongly stimulated g-globin promoter-LCR interactions with a concomitant decrease in b-globin-LCR contacts. Finally, previous 3C experiments demonstrated the sufficiency of tethered Ldb1 for full reconstitution of an LCR-b-globin promoter loop in immature adult erythroid cells in which the globin locus is otherwise unlooped (Deng et al., 2012) . Therefore, in aggregate these data strongly support that Ldb1 SA-induced transcriptional activation is a functional consequence of its impact on the higher-order chromatin organization within the b-globin locus.
Prior studies involving transgenic mice suggested that genomic proximity to the LCR correlates with the ability to compete for LCR activity, presumably because closer genes have a higher probability of forging a productive interaction (Bauchwitz and Costantini, 2000; Hanscombe et al., 1991; Peterson and Stamatoyannopoulos, 1993; Tanimoto et al., 1999) . We observed that bh1-SA not only activated bh1-globin expression but also, to some degree, activated the expression of εy-globin, which resides closer to the LCR than to bh1-globin. Similar to bh1-globin, εy-globin upregulation was dependent on the LCR. Therefore, the newly imposed spatial constraint of the LCR also increases the likelihood for interaction with a nearby gene. This lends further support to the idea that spatial proximity is a key determinant of enhancer activity.
Because numerous protein complexes orchestrate the developmental switch in b-globin gene expression , it came as a surprise that a single molecule could exert such strong activating effects on the embryonic or fetal globin genes in adult erythroid cells. This indicates that direct recruitment of the active LCR to the g-globin genes can effectively override its developmental repression. As a corollary, it is plausible that regulation of chromatin looping might also underlie the function of factors normally involved in globin gene switching. Indeed, Bcl11a, a potent silencing factor of the g-globin genes in human cells, does not detectably bind to the g-globin gene promoters but appears to regulate the looped configuration of the locus . Future studies analyzing the effects of forced LCR-g-globin looping on the various postulated g-globin repression mechanisms are expected to provide additional insights into the control of normal developmental globin switching.
Tethering the SA domain did not activate murine embryonic genes to the same level as the human fetal genes. This is consistent with a more stringent developmental repression within the murine environment (Sankaran et al., 2009 ). Exposure of developing human erythroid cells to in vitro culture conditions variably elevates basal fetal globin gene expression, suggesting that the human g-globin genes are in a poised and therefore more responsive state when compared to the murine embryonic genes. (Fibach et al., 1993) . Hence GG1-SA might act in an environment that is more favorable for further activation. It is also possible that the chromatin state at the fetal globin genes facilitates more efficient access of GG1-SA to its target site. However, even under the most restrictive conditions, as are found in murine cells, the silent bh1-gene promoter remains accessible to bh1-SA and allows for activation of bh1-globin expression up to 30% of total b-globin synthesis. In fact, such levels, if achieved at the fetal globin genes in human sickle cell anemia patients would be sufficient to ameliorate the clinical course of their disease (see also below) (Noguchi et al., 1988; Platt et al., 1991) . If desired, means to further increase the efficiency of embryonic or fetal globin transcription induction could be conceived. Improvements in ZF design or the use of multiple ZF proteins could potentially enhance the specificity and efficiency to raise the competitiveness of the targeted gene for enhancer activity. Alternative approaches for recruiting the SA domain, such as through TALEs or catalytically inactive CRISPR-Cas9 systems, could also be tested (Perez-Pinera et al., 2013; Sun et al., 2012) .
Currently, numerous strategies involving molecular genetic tools are being pursued with the goal to ameliorate sickle cell anemia. These include the transgenic expression of g-globin or antisickling forms of b-globin and genome editing to repair the sickle cell mutation or to diminish the expression of Bcl11a (Chandrakasan and Malik, 2014; Bauer et al., 2013; Hardison and Blobel, 2013) . These approaches, including the one presented here have specific strengths but also weaknesses that must be considered prior to their potential use in human patients. Several insights from our studies are relevant when considering a forced looping approach for therapeutic intervention. First, increases in fetal g-globin expression were accompanied by reduced adult b-globin expression. This agrees with the notion that the LCR is incapable of interacting with multiple globin promoters at once but instead contacts either the fetal genes or the adult genes (Enver et al., 1990; Wijgerde et al., 1995) . The reduction in adult b-globin expression might be an added therapeutic benefit because diminished synthesis of defective b-globin chains, as occurs in sickle cell anemia, would further improve the ratio of g-globin chains available to pair with the a-globin chains. Second, in normal adults, total fetal hemoglobin synthesis ranges below 3% but is concentrated in a small fraction of cells with high fetal hemoglobin expression (F-cells). However, GG1-SA expression raised fetal globin expression in the vast majority of transduced cells. Therefore, it is expected that in a therapeutic setting fewer dysfunctional erythroid cells would remain to contribute to disease. Finally, marked effects in fetal globin reactivation were achieved with relatively low levels of GG1-SA transgene expression (<1% of globin genes), which may be a more easily achievable and sustainable compared to what would be required if expressing a g-globin transgene.
In summary, we have shown that forced long-range chromatin interactions can be used to reactivate a developmentally silenced gene. When employed at a complex gene locus at which promoters compete for enhancer activity, this strategy can lead to a reciprocal reduction in the expression of alternate genes. Therefore, manipulation of chromatin looping can in principle be applied for gene activation or repression at any gene that is controlled by a looped distal enhancer. Refinements in targeted tethering technologies and the exploration of additional nuclear factors involved in chromatin looping are expected to increase the appeal of this technology for a wider range of applications.
EXPERIMENTAL PROCEDURES
Artificial Zinc-Finger Design Custom ZF proteins each containing six tandem Cys2-His2 domains were designed to target 18-19 base pairs at the bh1-globin promoter. ZFs were assembled from two-finger units and screened for DNA binding by ELISA assay in vitro as described previously (Bartsevich et al., 2003) . Chosen target sequences were within the DNase I hypersensitive region to facilitate access but to avoid interference with known transcription factor binding sites. Five ZFs were FLAG tagged and screened by anti-FLAG ChIP for in vivo binding to the bh1 promoter in G1E cells. Two of these produced sufficiently high ChIP signals with the desired specificity. The better of the two with the target sequence AAGGGGAGCAAGGTCCAG was used for experiments in this report. The lesser one also activated bh1 expression albeit to a lower degree (data not shown). The ZFs targeting HS2 of the mouse LCR and the human g-globin promoters have been described previously (Deng et al., 2012; Grä slund et al., 2005) .
Constructs
The bh1-globin zinc-finger cDNA was cloned into MigR1 retroviral vector with three Flag tags and a nuclear localization signal (NLS) at its N terminus. The SA domain containing amino acids 1-200 of Ldb1 was inserted C-terminal to the ZF. The lentiviral vectors pCL20 expressing the GG1 from the spectrin or ankyrin promoter were gifts from Andrew Wilber (Wilber et al., 2010) . The SA domain was attached C-terminal to GG1 tagged with HA. GG1-Only contains GG1 with an attached HA-tag.
Cell Culture G1E cells were cultured as described previously (Weiss et al., 1997) . G1E cells containing GATA1-ER were treated with 100 nM estradiol for indicated periods of time (denoted as G1E+GATA1). K562 cells were grown in IMDM medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.
Mouse Primary Erythroblasts
Fetal liver erythroid cells were isolated from strain-matched E13.5 wild-type or DLCR/DLCR embryos (129 strain) (Bender et al., 2000) , according to protocol 2012-7-660. Single-cell suspensions were reacted with PE-conjugated anti-CD71 and APC-conjugated anti-Ter119 antibodies and sorted by FACS. S0 and S1 populations ( Figure 2A) were infected with retrovirus and cultured for 43-48 hr in medium containing IMDM with 15% fetal bovine serum, 1% penicillin-streptomycin, 1% glutamine, 10 ng/ml mIL3, 20 ng/ml mIL6, 50 ng/ml mSCF, 10 ng/ml mFLT3L, 0.5 U/ml erythropoietin (Amgen), and 1 mM dexamethasone (Sigma).
Two-Phase Differentiation of Bone Marrow-Derived Human CD34+ Cells Human CD34+ cells were obtained from deidentified healthy bone marrow donors after informed consent by the University of Pennsylvania Stem Cell Core. Cells were expanded in StemSpan SFEM medium with 13 StemSpan CC100 cytokine cocktail (STEMCELL Technologies) and 1% penicillin-streptomycin, followed by differentiation in medium consisting of SFEM medium, 1 U/ml erythropoietin, 5 ng/ml IL3, 20 ng/ml SCF, 1 mM estradiol, and 2 mM dexamethasone. On day 10-12 of differentiation, GFP+ cells were sorted on a MoFlo XDP (Beckman Coulter) or an Ariall (BD Biosciences) cell sorter. Cell purity was confirmed by postsort flow cytometry.
Two-Phase Differentiation of Peripheral Blood-Derived Human CD34+ Cells Peripheral blood was obtained from healthy donors after obtaining written consent, in accordance with protocol 05070077971 from the Weill Cornell Medical College Institutional Review Board. The mononuclear fraction from a Ficoll-Hypaque density gradient was enriched for CD34+ cells by immunomagnetic separation using the CD34 Microbeads Kit (Miltenyi Biotec). Expansion and differentiation were achieved using a protocol as described previously (Breda et al., 2012) . Briefly, cells were expanded in StemSpan SFEM medium, 13 StemSpan CC100 cytokine cocktail, 2 U/ml Erythropoietin, 1 mM dexamethasone (Sigma), and 1% penicillin-streptomycin. Differentiation was induced in StemSpan SFEM medium, 10 ng/ml SCF, 10 mM b-mercaptoethanol, 10 U/ml erythropoietin, and 1% penicillin-streptomycin.
Viral Infections
Retroviral infections of G1E cells have been described (Tripic et al., 2009 ). For primary fetal liver cells, spin-infection conditions were modified to 2,000 rpm at room temperature for 1 hr with appropriate cytokines added, and cells were switched to fresh medium immediately after infection. Lentivirus was concentrated using Peg-it Virus Precipitation Solution (System Biosciences) or ultracentrifugation. Primary human cells were infected on two consecutive days starting at the second or third day of the expansion phase with freshly prepared virus. Cells were spin-infected at 2,250 rpm at room temperature for 1.5 hr with appropriate cytokines. K562 cells were spin-infected once using the same conditions.
Chromatin Immunoprecipitation
Anti-HA (clone 12CA5) and anti-Flag (clone M2, F3165, Sigma) ChIP was performed as described (Tripic et al., 2009 ) using primers listed in Table S1 .
qRT-PCR RNA from 10 5 -10 6 cells was extracted with Trizol (Invitrogen). Reverse-transcription reactions were performed with random hexamers using Superscript II (Invitrogen) or iScript (Bio-Rad). cDNA samples were quantified by SybrGreen qPCR. The primers for human b-globin amplify both b-globin and d-globin cDNA with d-globin contributing less than 6% of the total.
Immunostaining Human primary cells were stained with an APC-conjugated fetal hemoglobin antibody (Invitrogen, MHFH05) using the BD Cytofix/Cytoperm Kit (BD Biosciences), per the manufacturer's protocol. Surface staining was performed with PE-labeled antiCD71 and APC-labeled antiCD235a (BD Biosciences).
HPLC Analyses
Hemolysis of cells was achieved in ice water for 30 min and two cycles of freeze thawing. Hemoglobin content and quality were analyzed by HPLC as described previously (Ou and Rognerud, 1993) , using a PolyCAT A column (cat # 3.54CT0315; 3 m, 1500 Å PolyLC) on a System Gold 126 Solvent Module instrument (Beckman Coulter). Hemoglobins were measured at a wavelength of 415 nm and compared to hemoglobin standards with known concentration (Analytical Control System).
Chromosome Conformation Capture 3C assays were performed as described (Hagè ge et al., 2007) with the following modifications. Cells (2 3 10 6 ) were crosslinked with 1% formaldehyde at room temperature for 10 min, followed by glycine quenching, cell lysis, EcoRI digestion, and T4 ligation. 3C ligation products were quantified in triplicates by quantitative SYBR Green real-time PCR as described previously (Kiefer et al., 2011) . The 3C signals were normalized to template standards generated from a locus-specific BAC and to 3C signals from the tubulin locus.
To eliminate variability between donor samples, interaction frequencies between the anchor fragment and the fragment encompassing the G g-globin gene ( Figure 7A ) or the b-globin ( Figure S6B ) from the GG1-SA sample of each donor were set to one. Primer sequences are listed in Hou et al. (2010) , Kiefer et al. (2011) , and Table S1 .
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